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Condensation: 
Changes in condom use behavior was not different between women initiating LARC and women 
initiating non-LARC methods; however, the risk of incident STI was increased.  
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ABSTRACT 
Background: Use of more effective contraception may lead to less condom use and increased 
incidence of sexually transmitted infection.    
Objective: The objective of this study was to compare changes in condom use and incidence of 
sexually transmitted infection acquisition among new initiators of long-acting reversible 
contraceptives to those initiating non-long acting reversible contraceptive methods.  
Study Design: This is a secondary analysis of the Contraceptive CHOICE Project. We included 
two sample populations of 12-month continuous contraceptive users. The first included users 
with complete condom data (baseline, 3, 6, and 12 months) (long-acting reversible contraceptive 
users: n=2371; other methods: n=575). The second included users with 12-month sexually 
transmitted infection data (long-acting reversible contraceptive users: n=2102; other methods: 
n=592). Self-reported condom use was assessed at baseline and at 3, 6, and 12 months following 
enrollment. Changes in condom use and incident sexually transmitted infection rates were 
compared using chi-square tests. Risk factors for sexually transmitted infection acquisition were 
identified using multivariable logistic regression.  
Results: Few participants in either group reported consistent condom use across all survey time 
points and with all partners (long-acting reversible contraceptive users: 5.2%; other methods: 
11.3%, P<0.001).  There was no difference in change of condom use at 3, 6 and 12 months 
compared to baseline condom use regardless of method type (p=0.65).  A total of 94 incident 
sexually transmitted infections were documented, with long-acting reversible contraceptive users 
accounting for a higher proportion (3.9% vs. 2.0%; P=0.03).  Initiation of a long-acting 
reversible contraceptive method was associated with increased sexually transmitted infection 
incidence (OR 2.0, 95% CI: 1.07, 3.72). 
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Conclusions: Long-acting reversible contraceptive initiators reported lower rates of consistent 
condom use, but did not demonstrate a change in condom use when compared to pre-initiation 
behaviors. Long-acting reversible contraceptive users were more likely to acquire a sexually 
transmitted infection in the 12 months following initiation.  
 
Key words: Sexually transmitted infection, long-acting reversible contraception, LARC 
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Introduction 
Long acting reversible contraceptives (LARCs) are the most effective reversible methods 
of pregnancy prevention (1), however they do not provide protection against sexually transmitted 
infections (STIs) (2-6). Barrier methods, such as condoms, are the most effective method for STI 
prevention (2, 7), but have a typical use contraceptive failure rate of 15-17% (8, 9). Clinicians 
have long recommended dual protection with an effective contraceptive method along with 
condom use. Poor adherence to these recommendations poses a challenge to reliable prevention 
of both STIs and pregnancy (5-7, 10, 11). Several studies have suggested that rates of dual-
method use among LARC users is lower than among users of other short acting reversible 
methods (10, 12-15). Available literature indicates that across women of all reproductive ages, 
there is low adherence to dual-method use (6, 10). Studies evaluating factors associated with 
higher rates of dual-method compliance have shown age (5), race, and number of sexual partners 
(15), but not necessarily contraceptive method to be associated (16) with dual use. Most studies, 
however, have not specifically compared LARC to non-LARC users.  
Varying risk perception (5, 15), partner discordance in condom preference (15), 
intermittent or partner specific condom use (5, 6, 13), and potential social desirability and recall 
bias (2, 10, 12) make accurate assessment of condom use difficult. Additionally, few studies 
specifically evaluate the correlation between reported changes in condom use and acquisition of 
STIs. 
The objective of this analysis was to examine the change in condom use in women 
initiating LARC methods versus those initiating non-LARC methods, as well as to evaluate rates 
of incident STI in women initiating LARC and non-LARC methods.  We hypothesized that there 
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would be no difference in condom use behavior or incident STIs in women initiated LARC or 
non-LARC methods. 
 
Materials and Methods 
This is a secondary analysis of the Contraceptive CHOICE Project, a prospective cohort 
study in which 9,256 women were offered the contraceptive method of their choice at no cost for 
two to three years. Full details of this study have been previously published (17).  This analysis 
includes two distinct populations of participants that chose a method and continued using that 
method through 12-months (Figure 1). To evaluate changes in condom use behaviors, we 
included all participants who provided complete data (baseline, 3, 6 and 12 month surveys) on 
condom use (N=2946).  Condom use behaviors were collected through a series of questions. 
Participants were first asked to identify their current number of sexual partners, and if they had 
multiple partners, they were asked each question as it related to the main partner as well as their 
additional partner(s). Specifically, participants were asked “Since the last time we spoke, when 
you had vaginal or anal sex with your main (other) partner, how often did you use condoms?”  
Response options included every time, almost every time, sometimes, almost never, and never.  
The reason for condom use was also assessed by asking participants if condom use was for 
pregnancy prevention and/or STI prevention.  
To assess the impact of method on incident acquisition, we included all participants for 
whom STI testing results were available during the 12-month reference period (N=2694).  The 
CHOICE Project provided STI screening on an annual basis as well as any time a participant 
requested screening secondary to perceived exposure, or if they reported symptoms of infection. 
In addition to any testing that was completed at the research center, possible diagnosis and 
treatment at other facilities were captured at each survey point. STIs were identified using 
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nucleic acid amplification testing from self-collected swabs sent to each participant annually or 
in clinic collection (self-collected or clinician collected).  STI testing included Neisseria 
gonorrhoeae, Chlamydia trachomatis, and Trichomomonas vaginalis. Any reported or 
documented positive test was considered an incident infection.  
 The primary objective of this analysis is to evaluate the impact of method choice on 
condom use behaviors. Secondarily, we compare incident STI rates between LARC and non-
LARC initiators over a 12-month period. Demographic characteristics of the two cohorts are 
presented as means and standard deviations, or frequencies and percentages based on the data 
type. Student t-test or chi-square tests were performed to examine the differences in subjects’ 
characteristics between LARC and non-LARC users. Frequency of incident STI was calculated 
for LARC and non-LARC and compared using chi-square test. Condom use behaviors with both 
main partner and additional partners were evaluated at baseline, 3, 6, and 12 months. If 
participants reported different frequency of condom use with main partner versus other partners, 
the least frequent response was used. Changes in condom use from baseline to follow-up time 
points were categorized as less frequent use, more frequent use, and no change in use. 
Multivariable logistic regression models were used to evaluate the association between 
contraceptive method (LARC vs. non-LARC) and STI acquisition. Known risks factors and other 
clinically relevant factors were evaluated for their association with STI acquisition and for 
potential confounding effect. A confounder was identified if a greater than 10% change in the 
effect size was noted when the covariate was added to the model. All statistical tests were 
performed using Stata 12. Significance levels were set at type I error less than 0.05.  
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Results 
Of the 9,256 participants enrolled in the Contraceptive CHOICE Project, 6,135 (66%) 
were 12-month continuous users of the method they chose at baseline. LARC users comprised 
82% of this cohort (LARC: N=5016; non-LARC: N=1119). Of those continuous users, 2,946 
participants provided complete condom use behavior data (LARC: N=2371; non-LARC: 
N=575).  The mean age was 26.1 years in the LARC group and 24.4 years in the non-LARC 
group. The cohort was racially diverse amongst both LARC and non-LARC initiators. 
Participants who chose to initiate a non-LARC method were more likely to be younger, 
uninsured, single, and nulliparous (Table 1).  Among the 6,135 continuous users, 2694 
participants contributed STI results. LARC users comprised 78% of this analytic cohort (LARC: 
N=2102; non-LARC: N=592). This cohort was similar to the condom cohort. However, more 
LARC users reported a history of STI (LARC: 42.6% (895/2102); non-LARC: 34.6% (205/592) 
p<0.01).  
Consistent condom use, defined as use every time across all time points with all partners, 
was low for all participants (6.4% or 187/2946); however, non-LARC initiators were 
significantly more likely to report always using condoms (11.3%) as compared to LARC 
initiators (5.2%, P<0.001). While there was overall less consistent condom use among LARC 
users, the changes in condom use patterns from time of initiation through the 12-month study 
period was not significantly different (Table 2). Approximately 70% of participants in both 
LARC and non-LARC groups reported no change in their condom use behaviors when compared 
to baseline.  
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The overall incidence of incident STI in the cohort was 3.5% (96/2694).  There was a 
significant difference in STI incidence among LARC and non-LARC initiators (LARC: 3.9% 
(82/2102) versus non-LARC: 2.0% (12/5925), P=0.03). 
 After adjusting for potential confounding factors, use of LARC methods was associated 
with increased incidence of STIs (ORadj= 2.0; 95% CI 1.07, 3.72; Table 3). Several risk factors 
were found to be associated with increased risk for STI acquisition. Young women compared to 
women 25 years or older (ORadj=2.94; 95% CI 1.74, 4.97), black race (ORadj= 3.18; 95% CI 
1.91, 5.31), separated, divorced, or widowed marital status compared to married or living with 
partner (ORadj= 3.17; 95% CI 1.21, 8.26), and women with a new sexual partner (ORadj= 2.16; 
95% CI 1.40, 3.33) were at higher risk for STI acquisition (Table 3).  
 
Comments 
As the uptake of LARC has increased, several hypothesized themes of concern have 
emerged. Clinicians have raised the possibility that increased LARC use may also increase 
sexual risk taking behavior, may have negative effects on condom use (13, 19), and may increase 
rates of STI (12, 20). A previous analysis of the Contraceptive CHOICE data demonstrated that 
there was no increase in risk taking behavior (18). The purpose of this analysis was to evaluate 
the impact LARC initiation had on condom use as well as rates of incident STIs.  Our data, 
consistent with previously published studies, reaffirms that consistent condom use and dual 
contraceptive method use are low (5, 10, 11, 21) regardless of which additional contraceptive 
method is being used. Data from the 2006-2008 NSFG survey found 7.3% of women using any 
contraceptive method reported dual-method use at their most recent intercourse in the previous 
12 months (10). Although we present data for consistent condom use over 12 months, as opposed 
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to just the last act of intercourse, we too found a low incidence of consistent dual-method use 
(6.13%).  
Increasing rates of LARC use in the U.S., most recently reported as 11.6% (22), have 
renewed concerns that use of LARC may elevate risks of STI by less frequent use of condoms. 
Recent studies have evaluated condom use in LARC users and have demonstrated that LARC 
use does not compromise condom use (19, 21). Conversely, one early study evaluating dual-
method use in users of the Norplant found an overall decrease in condom use among women who 
initiated this LARC method (20). However, it was the cohort of women reporting one sexual 
partner where the largest decline was noted (20% to 10%) (20).  In the same cohort, women 
reporting more than one partner demonstrated an increase in reported condom use from 25% to 
31% (20). El Ayadi et al. reported findings from their cluster randomized trial in which LARC 
access was assessed after a provider targeted intervention to increase LARC was implemented.  
The authors assessed the impact of their intervention on condom use and STI incidence and did 
not find a negative impact on either (21). Our findings continue to support that initiation of 
LARC does not change the condom use behavior of women.  
The overall rate of incident STI in this analysis was 3.5%. Although we did demonstrate 
that LARC users were at increased risk (OR 2.0) of incident STI, the cohort maintained a low 
rate overall (3.9%). Regardless, this data highlights the importance of counseling contraceptive 
users on dual method protection.    
The strengths of this study include its large sample size and inclusion of participants who 
were continuous method users, allowing for more thorough evaluation of the impact of method 
on behaviors. We also utilized a rigorous evaluation of reported condom use over time. The 
study collected information about condom use at baseline, 3 months, 6 months, and 12 months. 
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Frequent contact with participants not only helped establish rapport but also likely helped to 
minimize recall bias.  An additional strength of this study is the measure of both a behavioral 
outcome (condom use) and an important biological endpoint (STI incidence). 
 This study was not without limitations. Including only those who completed STI 
screening may have falsely underestimated our STI detection rate, especially if participants at 
highest STI risk are those who have not been included. However, we feel that because we 
maintained frequent contact with participants and offered both testing and treatment free of 
charge, the likelihood that we had differential participation is low.  Frequent contact with 
participants, particularly when asking questions about sexual behavior and condom use, could 
have an effect in and of itself. Participants may have been more aware of the importance of 
condom use, or STI prevention influencing their behavior. As is true with all sensitive subjects, 
the potential for social desirability bias is unavoidable; however, we believe the relationship we 
had with our participants served to minimize this bias.  
 This study adds to the growing body of literature that provides reassurance that LARC 
use does not change condom use behavior. However, the slight increase in STI acquisition 
observed among LARC users highlights the importance of dual method education. Similar to 
previous reports, we noted that dual contraceptive method use is low, regardless of contraceptive 
method. Given the known benefits, healthcare providers should continue to encourage all at-risk 
patients to use dual-methods for STI and pregnancy prevention.  Clinicians should not limit 
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